Invention Grant
- Patent Title: Biomarkers and methods for predicting benefit of adjuvant chemotherapy
-
Application No.: US14765156Application Date: 2014-02-03
-
Publication No.: US10240206B2Publication Date: 2019-03-26
- Inventor: W. Douglas Cress , Dung-Tsa Chen
- Applicant: H. Lee Moffitt Cancer Center and Research Institute, Inc.
- Applicant Address: US FL Tampa
- Assignee: H. Lee Moffitt Cancer Center and Research Institute, Inc.
- Current Assignee: H. Lee Moffitt Cancer Center and Research Institute, Inc.
- Current Assignee Address: US FL Tampa
- Agency: Meunier Carlin & Curfman LLC
- International Application: PCT/US2014/014378 WO 20140203
- International Announcement: WO2014/121177 WO 20140807
- Main IPC: C12Q1/6886
- IPC: C12Q1/6886 ; G01N33/574 ; A61N5/10 ; G06F19/22
Abstract:
Biomarkers, methods, assays, and kits are provided for predicting the efficacy of adjuvant chemotherapy (ACT) in a subject with early-stage non-small cell lung cancer (NSCLC).
Public/Granted literature
- US20150376713A1 BIOMARKERS AND METHODS FOR PREDICTING BENEFIT OF ADJUVANT CHEMOTHERAPY Public/Granted day:2015-12-31
Information query
IPC分类:
